1844 participants
An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-09-20
- Start Date:
- 2017-04-11
- Completion:
- 2020-06-12
Conditions
- Melanoma
Interventions
- BIOLOGICAL